November 2, 2023 – The Society for Clinical Research Sites (SCRS) is proud to announce a strategic Global Impact Partnership with Science 37, marking the Society’s first and only fully virtual clinical trial site to participate in its expansive Global Impact Partner community.
“We are excited to announce our partnership with SCRS,” said David Coman, CEO of Science 37. “The Science 37 Metasite™ is at the forefront of a clinical research shift, as it breaks down geographical barriers and makes clinical trials more accessible. We look forward to collaborating with the SCRS team, along with its network of clinical research sponsors and sites to deliver a more patient-friendly and impactful research ecosystem.”
Science 37’s unique model reaches patients who do not have access to traditional brick-and-mortar clinical trial sites and enables them to participate from the comfort of their homes. Oversight is managed by telemedicine investigators, physical procedures are managed by mobile nurses, and patient support is provided by remote coordinators. The experience is powered by a proprietary platform that enables data collection and workflow orchestration that drives greater compliance to produce high-quality data.
Marcus Maleck, Vice President of Global Business Partnerships with SCRS also expressed enthusiasm about the collaboration, stating, “Science 37 is a pioneer in our industry ever since launching their decentralized clinical trials platform. Now, as the clinical research landscape evolves, they are incorporating their technology and expertise to expand patient access to trials. Their work in clinical trial innovation is invaluable to our site members and the industry as a whole. We look forward to collaborating towards our shared goal of empowering site success.”
About the Society for Clinical Research Sites
The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs.org. Our voice. Our community. Your success.
About Science 37
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to accelerate clinical research by enabling universal trial access for patients. Through our Metasite™ we reach an expanded population beyond the traditional site, delivering on our goal of clinical research that works for everyone—with greater patient diversity. Patients gain the flexibility to participate from the comfort of their own homes, at their local community provider, or at a traditional site when needed. Our Metasite is powered by a proprietary technology platform with in-house medical and operational experts that drive uniform study orchestration, enabling greater compliance and high-quality data. To learn more, visit www.science37.com, or email firstname.lastname@example.org.